Nu Skin Enterprises (NYSE:NUS) Updates FY 2025 Earnings Guidance

Nu Skin Enterprises (NYSE:NUS) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided EPS guidance of 0.900-1.300 for the period, compared to the consensus EPS estimate of 0.760. The company issued revenue guidance of $1.5 billion-$1.6 billion, compared to the consensus revenue estimate of $1.7 billion. Nu Skin Enterprises also updated its Q1 2025 guidance to 0.100-0.200 EPS.

Nu Skin Enterprises Stock Up 17.4 %

NYSE:NUS opened at $7.54 on Friday. Nu Skin Enterprises has a twelve month low of $5.95 and a twelve month high of $14.64. The company has a current ratio of 1.93, a quick ratio of 1.20 and a debt-to-equity ratio of 0.53. The stock has a fifty day simple moving average of $6.89 and a 200-day simple moving average of $7.49.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings data on Thursday, February 13th. The company reported $0.38 earnings per share for the quarter, beating analysts’ consensus estimates of $0.24 by $0.14. Nu Skin Enterprises had a negative net margin of 5.81% and a positive return on equity of 5.47%. Research analysts expect that Nu Skin Enterprises will post 0.68 EPS for the current year.

Nu Skin Enterprises Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 5th. Investors of record on Monday, February 24th will be paid a $0.06 dividend. The ex-dividend date is Monday, February 24th. This represents a $0.24 annualized dividend and a yield of 3.19%. Nu Skin Enterprises’s dividend payout ratio (DPR) is currently -11.59%.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. StockNews.com upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Monday, November 11th. DA Davidson lowered their price objective on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating for the company in a research note on Friday, December 20th. Finally, Citigroup cut their target price on shares of Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating on the stock in a research report on Tuesday, October 22nd.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.